Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats

Human Gene Therapy

Volumn 7, Issue 18, 1996, Pages 2273-2279

  Lei, Dinghua ^a   Lehmann, Manfred ^b   Shellito, Judd E ^a   Nelson, Steve ^a   Siegling, Angela ^c   Volk, Hans Dieter ^c   Kolls, Jay K ^a,d  

^a LSU Section of Pulmonary/Critical Can Medicine   (United States)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d LSU Sect Pulmon/Critical Care MEB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; GENE TRANSFER; IMMUNOMODULATION; LIVER; LUNG; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; RAT; REPORTER GENE; TRANSGENE;

ADENOVIRIDAE; ANIMALIA;

EID: 0030480876     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.18-2273     Document Type: Article

References (37)

1. BINDER, J., LEHMANN, M., GRASER, E., HANCOCK, W.W., WATSCHINGER, B., ONODERA, K., SAYEGH, M.H., VOLK, H.D., and KUPIEC-WEGLINSKI, J.W. (1996). The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 61, 804-811.
2. COBBOLD, S.P., QIN, S., and WALDMANN, H. (1990). Reprogramming the immune system for tolerance with monoclonal antibodies. Sem. Immunol. 2, 377-387.
3. COBBOLD, S.P., QIN, S., LEONG, L.Y.W., MARTIN, G., and WALDMANN, H. (1992). Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol. Rev. 129, 165-201.
4. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W. W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
5. EMBREE, L., WILSON, C.B., SCHOWALTER, D.B., LINSLEY, P., ARUFTO, S., ALBERT, R.K., and KAY, M. (1996). Blocking T cell-B cell costimulatory interactions prolongs airway epithelial gene expression induced by an adenoviral vector. [Abstract] Am. J. Respir. Crit. Care Med. 153, (4)A764.
6. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
7. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
8. GOMEZ-FOIX, A.M., COATS, W.S., BAQUE, S., ALAM, T., GERARD, R.D., and NEWGARD, C.B. (1992). Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267, 25129-25134.
9. GUERRETTE, B., VILQUIN, J.T., GINGRAS, M., GRAVEL, C., WOOD, K.J., and TREMBLAY, J.P. (1996). Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum. Gene Ther. 7, 1455-1463.
10. KAY, M.A., HOLTERMAN, A.X., MEUSE, L., GOWN, A., OCHS, H.D., LINSLEY, P.S., and WILSON, C.B. (1995). Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11, 191-197.
11. KOLLS, J., PEPPEL, K., SILVA, M., and BEUTLER, B. (1994). Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91, 215-219.
12. KOLLS, J.K., LEI, D., GREENBERG, S., NELSON, S., and BEUTLER, B. (1995). Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary heart defense. J. Infect. Dis. 171, 570-575.
13. KOLLS, J.K., LEI, D., ODOM, G., NELSON, S., SUMMER, W.R., GERBER, M.A., and SHELLITO, J.E. (1996). Use of transient CD4-lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum. Gene Ther. 7, 489-497.
14. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
15. LEHMANN, M., STERNKOPF, F., METZ, F., BROCK, J., DOCKE, W., PLANTIKOW, A., KUTTLER, B., HAHN, H.J., RINGEL, B., and VOLK, H. (1992). Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 54, 959-962.
16. LEHMANN, M., SIEGLING, A., GORDALLA, A., RIEDEL, H., LACHA, J., HAHN, H.J., BROCK, J., and VOLK, H. (1993). Characterization of the anti-CD4-induced permanent acceptance of rat renal allografts. Transplant. Proc. 25, 2859-2860.
17. LOCHMÜLLER, H., PETROF, B.J., ALLEN, C., PRESCOTT, S., MASSIE, B., and KARPATI, G. (1995). Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. Biochem. Biophys. Res. Commun. 213, 569-574.
18. MANDUJANO, F.J., D'SOUZA, N.B., NELSON, S., SUMMER, W.R., BECKERMAN, R.C., and SHELLITO, J.E. (1995). Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice. Am. J. Respir. Crit. Care Med. 151, 1233-1238.
19. MASTRANGELI, A., HARVEY, B.G., YAO, J., WOLFF, G., KOVESDI, I., CRYSTAL, R.G., and FALCK-PEDERSEN, E. (1996). "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7, 79-87.
20. + T cell counts. Arthritis Rheum. 37, 834-838.
21. POWELSON, J.A., KNOWLES, R.W., DELMONICO, F.L., KAWAI, T., MOURAD, G., PREFFER, F.I., COLVIN, R.B., and COSIMI, A.B. (1994). CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation 57, 788-793.
22. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAM, M., STIER, L.E., PAAKKO, P., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
23. SHELLITO, J.E., KOLLS, J.K., OLARIU, R., and BECK, J.M. (1996). Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173, 432-439.
24. SHIZURU, J.A., ALTERS, S.E., and FATHAM, C.G. (1992). Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunol. Rev. 129, 105-130.
25. STRATFORD-PERRICAUDET, L.D., BRIAND, P., and PERRICAUDET, M. (1992). Feasibility of adenovirus-mediated gene transfer in vivo. Bone Marrow Transpl. 9s, 151-152.
26. SULLIVAN, D., DASH, S., DU, H., HIRAPATSU, N., GERBER, L., KOLLS, J., BLANCHARD, I., BASKIN, G., and GERBER, M.A. (1995). Gene therapy studies in non-human primates. [Abstract] Hepatology 22, 376A.
27. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
28. VOLK, H. SIEGLING, A., PLATZER, C., BROCK, J., EMMRICH, F., and LEHMANN, M. (1994). Tolerance induction by anti-CD4 Mab treatment in a rat kidney transplantation model. Transplant. Proc. 26, 3155-3156.
29. WILSON, J.M. (1995). Gene therapy for cystic fibrosis: Challenges and future direction. J. Clin. Invest. 96, 2547-2554.
30. WILSON, C., and KAY, M.A. (1995). Immunomodulation to enhance gene therapy. Nature Med. 1, 887-889.
31. YANG, Y., ERTL, H.C., and WILSON, J.M. (1994a). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.
32. YANG, Y., NUNES, F.A., BERENSCI, K., FURTH, E., GONCZOL, E., and WILSON, J.M. (1994b). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
33. YANG, Y., NUNES, F.A., BERENSCI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994c). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
34. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995a). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
35. YANG, Y., TRINCIERI, G., and WILSON, J.M. (1995b). Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1, 890-893.
36. YEH, P., DEDIEU, J.F., ORSINI, C., VIGNE, E., DENEFLE, P., and PERRICAUDET, M. (1996). Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70, 559-565.
37. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.